SCM
HAE icon

Sterling Capital Management’s Haemonetics HAE Stock Holding History

Sterling Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8K Sell
210
-94
-31% -$6.04K ﹤0.01% 1990
2026
Q1 		$17.1K Sell
304
-9
-3% -$586 ﹤0.01% 2091
2025
Q4 		$25.1K Buy
313
+196
+168% +$13.2K ﹤0.01% 2104
2025
Q3 		$5.7K Sell
117
-5
-4% -$309 ﹤0.01% 2729
2025
Q2 		$9.1K Buy
122
+69
+130% +$4.57K ﹤0.01% 2186
2025
Q1 		$3.37K Buy
53
+2
+4% +$136 ﹤0.01% 2357
2024
Q4 		$3.98K Buy
51
+1
+2% +$80 ﹤0.01% 2553
2024
Q3 		$4.02K Buy
+50
New +$4.04K ﹤0.01% 1849

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sterling Capital Management's HAE Position: Q2 2026 in Review

Sterling Capital Management reduced its Haemonetics (HAE) stake by 31% in Q2 2026, selling an estimated $6.04K and leaving 210 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

Sterling Capital Management first reported a position in HAE in Q3 2024 and has held it in 8 quarters since. The position peaked at $25.1K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Sterling Capital Management held 210 shares of Haemonetics worth $15.8K as of Q2 2026.
  • Sterling Capital Management sold 94 Haemonetics shares in Q2 2026, an estimated $6.04K.
  • Haemonetics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1990 holding.
  • Sterling Capital Management first reported a position in Haemonetics in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Haemonetics position peaked at $25.1K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.